Nonalcoholic fatty liver disease: from clinical recognition to treatment.
about
Omega-3 polyunsaturated fatty acids for non-alcoholic fatty liver diseaseCombination of conjugated linoleic acid with fish oil prevents age-associated bone marrow adiposity in C57Bl/6J mice.Effective therapy using voglibose for nonalcoholic steatohepatitis in a patient with insufficient dietary and exercise therapy: exploring other treatment possibilities.Genetic polymorphism in CD14 gene, a co-receptor of TLR4 associated with non-alcoholic fatty liver disease.The predictive value of steatosis in hepatitis C virus infection.The increasing burden of potentially preventable liver disease among adult liver transplant recipients: A comparative analysis of liver transplant indication by era in Australia and New Zealand.
P2860
Nonalcoholic fatty liver disease: from clinical recognition to treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nonalcoholic fatty liver disease: from clinical recognition to treatment.
@en
Nonalcoholic fatty liver disease: from clinical recognition to treatment.
@nl
type
label
Nonalcoholic fatty liver disease: from clinical recognition to treatment.
@en
Nonalcoholic fatty liver disease: from clinical recognition to treatment.
@nl
prefLabel
Nonalcoholic fatty liver disease: from clinical recognition to treatment.
@en
Nonalcoholic fatty liver disease: from clinical recognition to treatment.
@nl
P2860
P356
P1476
Nonalcoholic fatty liver disease: from clinical recognition to treatment.
@en
P2093
Stephanos J Hadziyannis
Vassilios A Sevastianos
P2860
P356
10.1586/17474124.2.1.59
P577
2008-02-01T00:00:00Z